Skip to main content

JPMORGAN CHASE & CO

Position in HALO — Halozyme Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in HALO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$38,033,111
-$2,924,855 QoQ
Shares Held
485,922
-23.3% QoQ
Ownership
0.428%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 667 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 61% Shared 0% None 39%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. HALO ranks #43 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HALO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $38,033,111 485,922
2026-03-31 $40,957,966 633,730
2025-12-31 $29,244,336 434,537
2025-09-30 $56,313,381 767,840
2025-06-30 $53,867,643 1,035,518
2025-03-31 $157,918,577 2,474,825
2024-12-31 $114,145,844 2,387,489
2024-09-30 $163,984,408 2,864,857
2024-06-30 $160,842,269 3,071,854
2024-03-31 $131,823,413 3,240,497
2023-12-31 $114,351,722 3,093,932
2023-09-30 $120,836,718 3,163,265
2023-06-30 $126,068,072 3,495,095
2023-03-31 $134,534,811 3,522,776
2022-12-31 $183,660,509 3,227,777
2022-09-30 $155,511,845 3,933,026
2022-06-30 $179,900,248 4,088,642
2022-03-31 $200,986,065 5,039,771
2021-12-31 $206,128,560 5,126,301
2021-09-30 $214,157,375 5,264,439
2021-06-30 $238,638,993 5,255,208
2021-03-31 $213,414,526 5,119,082
2020-12-31 $222,201,847 5,202,572
2020-09-30 $130,616,565 4,970,189
2020-06-30 $133,088,699 4,964,144
2020-03-31 $87,573,285 4,867,887